Restoring pulmonary surfactant membranes and films at the respiratory surface

Biochim Biophys Acta Biomembr. 2017 Sep;1859(9 Pt B):1725-1739. doi: 10.1016/j.bbamem.2017.03.015. Epub 2017 Mar 21.

Abstract

Pulmonary surfactant is a complex of lipids and proteins assembled and secreted by the alveolar epithelium into the thin layer of fluid coating the respiratory surface of lungs. There, surfactant forms interfacial films at the air-water interface, reducing dramatically surface tension and thus stabilizing the air-exposed interface to prevent alveolar collapse along respiratory mechanics. The absence or deficiency of surfactant produces severe lung pathologies. This review describes some of the most important surfactant-related pathologies, which are a cause of high morbidity and mortality in neonates and adults. The review also updates current therapeutic approaches pursuing restoration of surfactant operative films in diseased lungs, mainly through supplementation with exogenous clinical surfactant preparations. This article is part of a Special Issue entitled: Membrane Lipid Therapy: Drugs Targeting Biomembranes edited by Pablo V. Escribá.

Keywords: ARDS; Air-liquid interface; Exogenous surfactant therapy; Meconium aspiration sindrome; NRDS; Respiratory mechanics.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Humans
  • Lung / chemistry*
  • Meconium Aspiration Syndrome / drug therapy
  • Meconium Aspiration Syndrome / etiology
  • Pulmonary Surfactants / pharmacology
  • Pulmonary Surfactants / therapeutic use*
  • Respiratory Distress Syndrome / drug therapy
  • Respiratory Distress Syndrome / etiology
  • Respiratory Distress Syndrome, Newborn / drug therapy
  • Respiratory Distress Syndrome, Newborn / etiology

Substances

  • Pulmonary Surfactants